Table 10.
BNP | NO | RVH | FEC | QoL | ||
---|---|---|---|---|---|---|
aerobic ET | [79] Souza-Rabbo et al. (2008) | |||||
+ | [80] Handoko et al. (2009) | |||||
0 | + | 0 | [77] Shoemaker et al. (2009) | |||
+/0 | + | [69] Chan et al. (2013) | ||||
[81] Colombo et al. (2013) | ||||||
0 | + | [88] Weinstein et al. (2013) | ||||
[82] Colombo et al. (2015) | ||||||
+ | 0 | [83] Moreira-Gonçalves et al. (2015) | ||||
+ | [75] Natali et al. (2015) | |||||
0 | [84] Colombo et al. (2016) | |||||
0 | [85] Nogueira-Ferreira et al. (2016) | |||||
+ | [86] Pacagnelli et al. (2016) | |||||
+ | [74] Enache et al. (2017) | |||||
- | [45] Zimmer et al. (2017) | |||||
0 | 0 | 0 | + | + | [77] Brown et al. (2018) | |
anaerobic ET | 0 | 0 | + | + | [73] Gerhardt et al. (2017) | |
HIIT | + | + | + | [42] Brown et al. (2017) | ||
combined ET | 0 | +/0 | [89] Man et al. (2009) | |||
+ | [90] Mainguy et al. (2010) | |||||
0 | 0 | [91] Martínez-Quintana et al. (2010) | ||||
0 | + | [92] Fox et al. (2011) | ||||
0 | +/0/− | 0 | [53] Ganderton et al. (2011) | |||
combined ET + RMT | + | + | [11] Mereles et al. (2006) | |||
0 | + | + | [37] Grünig et al. (2011) | |||
+ | + | [12] Grünig et al. (2012a) | ||||
0 | + | + | [93] Grünig et al. (2012b) | |||
- | + | 0 | [36] Becker-Grünig et al. (2013) | |||
+ | [94] Ley et al. (2013) | |||||
+ | [95] Kabitz et al. (2014) | |||||
0 | + | 0 | [96] Ehlken et al. (2016) | |||
0 | 0 | + | + | [97] Bussotti et al. (2017) | ||
0 | + | + | [98] González-Saiz et al. (2017) |
The combination +/0 or +/0/− is due to the fact that some studies used different tests. BNP, brain natriuretic peptide; ET, exercise training; FEC, functional exercise capacity; HIIT, high intensity interval training; NO, nitric oxide; QoL, quality of life; RMT, respiratory muscle training; RVH, right ventricular hypertrophy.